Τόμος 8 (1994) – Τεύχος 3 – Άρθρο 3 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 8 (1994) – Issue 3 – Article 3 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

1. 2^nd Dept, of Cardiology, 2. Laboratory of Experimental Pharmacology, Faculty of Medicine, Aristotelian University of Thessaloniki, Thessaloniki, Macedonia, Greece

Accepted for publication: 30 November 1994

pharmakonpress[at]pharmakonpress[.]gr

2.    Kotoula M, Kokkas V, Papadopoulos C, Paradelis A: Action de la cinnarizine sur l’aorte du rat. Epitheor. K Un. Farmakoi Farmakokinet, tnt. Ed. 2: 103-109 (1988)

3.    Papadopoulos C, Kotoula M, Kokkas V, Paradelis A: Angiokinetic effects of piracetam in vitro. Int. J. Immunopathol. Pharmacol. 2: 49-54 (1989)

4.    Kokkas V, Papadopoulos C, Kotoula M, Paradelis A: Vasomotor action of succinylcholine in vitro. MU. Forces Med. Rev. (Gr) 23: 209-202 (1989)

5.    Papadopoulos C, Kokkas V, Kotoula M, Kouyoumtzis A, Paradelis A: Interaction between verapamil and noradrenaline on the rat aortic strip. Hell. Armed Forces Med. Rev. 20: 415-418 (1986)(Gr)

6.    Papadopoulos C: Vasomotor Actions on the Coronary Arteries. Epitheor. Kiin. Farmakol. Farmakokinet, int. Ed. 3. 3-12 (1989)

7.    Kokkas V, Kotoula A, Kouyoumtzis A et al: The influence of Methionine-5-Encephalin on Calcium Uptake by the Bovine Aortic Media. Meth. Find. Exp. din. Pharmacol. 12: 181-184 (1990)

8.    Kokkas V, Kouyoumtzis M, Kotoula M et al: The action of Dynorphin 1-13 on Calcium uptake be bovine Aortic Tissue. Int. J. Immunopathol. and Pharmacol. 4: 91-97 (1991)

9.    Kokkas V, Papadopoulos CL, Sakadamis GC: How Catecholamines Control the Vascular Tone and the Behaviour of Platelets. Epitheor. Klin. Farmakol Farmakokinet, El. Ed 5: 229-236 (1987)

10.  Kouvelas D, Kokkas V, Papadopoulos C et al: Synergism of Naloxone and Morphine of the Vascular Tone. Epitheor. Klin. Farmakol. Farmakokinet, Int. Ed. 4. 178-181 (1990)

11.  Papadopoulos C, Kokkas B, Kotridis P, Gitsios C. The effect of β₁-blocker bisoprolol on atrial natriuretic peptide plasma levels in hypertensive patients. Intern. J Angiol. (in press).

12.  Kokkas B, Kouvelas D, Gerassopoulos M, Kotoula M, Kouyoumtzis A, Papadopoulos C, Paradellis AG. Cefamandole and Ca²⁺ uptake by the bovine aortic media. J Chemother. 1994 (in press)

13.  Cox JA: Calcium calmodulin interaction and cellular functions. J. Cardiovasc. Pharmacol. 8: 548 (1986)

14.  Klee CB, Ni WC, Draetta J et al: Different modes of interaction of calmodulin with its target enzymes. J. Cardiovasc. Pharmacol. 8: 552 (1986)

15.  Adelstein RS, Eisenberg E: Regulation and kinetics of the actin-myosin-ATP interactions. Rev. Biochem. 49: 921 (1980)

16.  Murphy RA. Mechanism of Contraction in Vascular Smooth Muscle. In: Swales JD (ed). Textbollk of Hypertension, pp. 139-145 Blakwell, Oxford, 1994

17.  Hartshorne DJ: Biochemical basis for contraction of vascular smooth muscle. Chest 78: 140 (1980)

18.  Schaub MC, Kunz B: Regulation of contraction in cardiac and smooth muscles. J. Cardiovasc. Pharmacol. 8: S117 (1986)

19.  Apostolakis Ml. Essential of Human Physiology. Kyriakidis, Thessaloniki: 1991-1994 (Gr).

20.  Plessas S.T. Human Physiology. PHARMAKON-Press Athens 1994 (Gr).

21.  Murphy RA, Askoy MD, Dillon PF et al: The role of myosin light chain phosphorylation in regulation of the crossbridge cycle. Fed. Proc. 42: 51 (1983)

22.  Berridge MJ: Inositol triphosphate and calcium mobilization. J. Cardiovasc. Pharmacol. 8: 585 (1986)

23.  Fleckenstein R: Specific pharmacology of calcium in myocardium cardiac pacemakers and vascular smooth muscle. Ann. Rev. Pharmacol. Toxicol. 17: 149 (1977)

24.  Bevan JA, Bevan RD, Hwa HH et al: Calcium regulation in vascular smooth muscle. Is there a pattern to its variability within the arterial tree? J. Cardiovasc. Pharmacol. 8: S71 (1986)

25.  Hermsmeyer K, Trapani A, Abel PW: Membrane-potential dependent tension in vascular muscle. In: Vasodilatation (P.M. Vanhoutte, I. Leusen, eds), p. 273, Raven, New York, 1981

26.  Carafoli E, Crompton M: The regulation of intracellular calcium. Curr. Top. Membr. Transp. 10: 151 (1978)

27.  Rusch NJ, Kotchen TA. Vascular Smooth Muscle Regulation by Calcium, Magnesium and Potassium in Hypertension. In: Swales JD (ed). Textbook of Hypertension, pp. 18198, Blakwell, Oxford 1994

28.  Somlyo AP, Somlyo AV: Electron probe analysis of calcium content and movements in sarcoplasmic reticulum, endoplasmic reticulum, mitochondria and cytoplasm. J. Cardiovasc. Pharmacol. 8: S42 (1986)

29.  Kazazoglou T, Schmid A, Renaud JF, Lazdunski M: Ontogenic appearance of Ca²⁺ channels characterized as binding sites for nitrendepine during development of nervous, skeletal and cardiac muscle systems in the rat. FEBS Lett. 164: 75 (1983)

30.  Triggle DJ: Calcium Antagonists. In: Antonaccio M (editor): Cardiovascular Pharmacology. 3^rd Ed. pp. 107-160, Raven New York, 1990

31.  Blaustein Mp, Nelson MT: Sodium-calcium exchange. In: Membrane Transport of Calcium (E. Carafoli, ed.), p. 217, Academic Press, New York, 1982

32.  Schwartzmann HJ: Calcium extrusion across the plasma membrane by the Ca²⁺-Na⁺ exchange system. In: Calcium and the Cell Physiology (D. Marme, ed.), Springer, Berlin. New York, 1985

33.  Heizmann CW: Intracellular calcium-binding proteins. J. Cardiovasc. Pharmacol. 8: S7 (1986)

34.  Saida K, Van Breemen C: Cyclic AMP modulation of adrenoreceptor mediated arterial smooth muscle contraction. J. Gen. Physiol. 84: 307 (1984)

35.  Murad F, Waldman SA, Fiscus RR, Rapport RM: Regulation of cyclic GMP synthesis and the ineractions with calcium. J. Cardiovasc. Pharmacol. 8: S57 (1986)

36.  Jakobs KH, Watanabe Y, Baner S: Interactions between the hormone-sensitive adenylate cyclase system and the phosphoinositide-metabolizing pathway in human platelets. J. Cardiovasc. Pharmacol. 8: S61 (1986)

37.  Challiss RAJ, Gray DW: Second Messenger Systems. In: Swales JD (ed). Textbollk of Hypertension, pp. 131-139, Blakwell, Oxford 1994

38.  Papadopoulos C, Sakadamis G, Kokkas B. cAMP as intravascular vasodilator mediator. Epitheor. Klin. Farmakol. Farmakokinet, El. Ed 5: 54-59 (1987)

39.  Hardman JG: Cyclic nucleotides and regulation of vascular smooth muscle. J. Cardiovasc. Pharmacol. 6: S639 (1984)

40.  Norman Rl. Membrane Biochemistry. In: Swales JD (ed). Textbollk of Hypertension, pp. 120-131, Blakwell, Oxford 1994

41.  Ross E, Gilman: Pharmacodynamics: Mechanisms of drug action and the relationship between, concentration and effect. In: Gilman Goodman A, Goodman LS, RAII TW, Murad F (eds): Goodmary and Gilman’s. The Pharmacological Basis of Therapeutics, 6ed., pp.35-48, MacMitlan, N.Y. 1985

42.  Paradellis Ath. Clinical Pharmacology. Thessaloniki, University Studio Press 1992 (Gr)

43.  Clemo HF, Feher JJ, Baumgarten CM. Modulations of rabbit ventricular cell volume and Na⁺/K⁺/2Cl^– cotransport by cGMP and atrial natriuretic factor. J. Gen Physiol. 100: 89-114 (1992)

44.  Clemo HF, Baumgarten CM. Atrial natriuretic factor decreases cell volume of rabbit atrial and ventricular myocytes. Am J Physiol. 260: C681-690 (1991)

45.  Clemo HF, Baumgarten CM, Stambler BS, Wood MA, Ellenbagen KA. Atrial natriuretic factor. PACE 17: 70-91 (1994)

46.  Papadopoulos C, Sakadamis G, Kokkas B. The role of cGMP in the regulation of the vascular tone. Epitheor. Klin. Farmakol. Farmakokinet, El. Ed 5: 123-127 (1987)

47.  Langer SZ, Hicks PE: Alpha-adrenoceptor sybtypes in blood vessels. J. Cardiovasc. Pharmacol. 6: S547 (1984)

48.  Van Nueten JM, Janssen PAJ, Van Beek J. et al.: Vascular effects of ketanserin a novel antagonist of 5-HT2 serotonergic receptors. J. Pharmacol. Exp. Ther. 218: 217 (1981)

49.  Marshall I: Characterization and distribution of histamine H1, and H2-receptors in precapillary vessels. J. Cardiovasc. Pharmacol. 6: S587 (1984)

50.  Ragoli D: Neurochumoral regulation of precapillary vassels: The Kallikrein-Kinin system. J. Cardiovasc. Pharmacol. 6: S401 (1984)

51.  Capponi AM, Aquilera G, Fakunding JL, Catt KL: Angiotensin II receptors and mechanisms of action. In: Biochemical regulation of Blood Pressure (RL Soffer, ed.), p. 205, J. Wiley and Sons, New York, 1981

52.  Kokkas B, Papadopoulos C, Sakadamis G. Vasomotor actions of ATP. Epitheor. Klin. Farmakol. Farmakokinet, El. Ed 5: 167-172 (1987)

53.  Lefkowitz RJ, Stadel JM, Caron MG: Adenylate cyclase-coupled beta-adrenergic receptors. Ann. Rev. Biochem. 52: 159 (1983)

54.  Manfredi JP, Sparks HV: Adenosine’s role in coronaryvasodilation induced by arterial pacing and norepinephrine. Am. J. Physiol. 240: H536 (1982)

55.  Berkowitz BA: Dopamine and dopamine receptors as target sites for cardiovascular drug action. Fed. Proc. 42: 3019 (1983)

56.  Papadopoulos C, Kokkas B, Kotridis P, Gitsios C, Sakadamis G, Kanonides J, Faitatziadis D, Pilis A, Theodorides E, Paradellis A.: Plasma atrial natriuretic peptide in essential hypertension after angiotensin converting enzyme inhibition. Int. J Angiol (in press).

57.  Katusic ZS, Vanhoutte P: Anoxic contractions in isolated canine cerebral arteries: Contribution of endothelium-derived factors, metabolites of arachidonic acid, and calcium entry. J. Cardiovasc. Pharmacol. 8: S97 (1986)

58.  Luscher TF. Local Relaxant and Constricting Factors in the Vessel Wall. In Swales JD (ed). Textbollk of Hypertension, pp. 145-159, Blakwell, Oxford 1994

59.  Rubanyi GM, Freay AD, Johns A, van Breemen C.: Elevated transmural pressure inhibits the release of EDRF by mechanism(s) similar to high K⁺ and barium. In: Mulvany MJ (ed). Resistance Arteries, Structure and Function, pp. 226-232, Elsevier, New York, 1991

60.  Langer SZ Presynaptic regulation of the release of catecholamines. Pharmacol. Rev. 32: 337 (1981)

61.  Receptor Nonenclature Supplement. TiPS Elsevier, New York, 1991

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr